Back to funds

ACUTA CAPITAL PARTNERS, LLC

Updated 6 days ago

Managed by Acuta Capital Partners, Llc • Latest filing Q3 2026

Portfolio value
$131.6M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
98.5%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$147.3M
Q1 2026$141.8M
Q2 2026$143.5M
Q3 2026$131.6M

Top holdings

35 positions as of Q3 2026

View filing
P

PRAXIS PRECISION MEDICINES I

Value
$24.5M
Shares
84.2K
% Port
18.63%
W

WHITEHAWK THERAPEUTICS INC

Value
$17.6M
Shares
4.69M
% Port
13.39%
T

TANGO THERAPEUTICS INC

Value
$10.2M
Shares
409.5K
% Port
7.76%
F

4D MOLECULAR THERAPEUTICS IN

Value
$7.7M
Shares
535.1K
% Port
5.82%
A

ARGEN SE - ADR

Value
$5.3M
Shares
5.6K
% Port
4.05%
A

ARRIVENT BIOPHARMA INC

Value
$5.2M
Shares
170.9K
% Port
3.93%
?
7.N/A

SURROZEN INC

Value
$4.9M
Shares
152.5K
% Port
3.73%
V

VOGENX INC

Value
$4.9M
Shares
213.2K
% Port
3.69%
D

BRIGHT MINDS BIOSCIENCES INC

Value
$4.6M
Shares
93.2K
% Port
3.53%
O

OCULAR THERAPEUTIX INC

Value
$4.4M
Shares
574.5K
% Port
3.35%
S

SILENCE THERAPEUTICS PLC

Value
$4.3M
Shares
393.6K
% Port
3.27%
T

TAYSHA GENE THERAPIES INC

Value
$3.4M
Shares
691.8K
% Port
2.56%
A

AVALYN PHARMA INC

Value
$3.3M
Shares
114.7K
% Port
2.48%
A

AVALO THERAPEUTICS INC

Value
$2.9M
Shares
186.3K
% Port
2.17%
M

MOONLAKE IMMUNOTHERAPEUTICS

Value
$2.5M
Shares
216.6K
% Port
1.93%
I

OPUS GENETICS INC

Value
$2.5M
Shares
514.1K
% Port
1.89%
N

MINERVA NEUROSCIENCES

Value
$2.4M
Shares
729.5K
% Port
1.86%
L

LB PHARMACEUTICALS INC

Value
$2M
Shares
52.7K
% Port
1.54%
A

ACADIA PHARMACEUTICALS INC

Value
$2M
Shares
1.0K
% Port
1.53%
A

ARTIVA BIOTHERAPEUTICS INC

Value
$1.9M
Shares
260.4K
% Port
1.41%

Explore